{"schema_version":"secwatch.filing_event.v1","accession":"0001832511-26-000032","form_type":"8-K","ticker":"PIII","cik":"0001832511","company_name":"P3 Health Partners Inc.","filed_at":"2026-08-10T20:03:10+00:00","discovered_at":"2026-08-10T20:04:00.362311+00:00","generated_at":"2026-08-10T20:04:12.058991+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"P3 Health Partners Q2 2026: Net income $15.7M vs loss, raises FY adjusted EBITDA guidance to $80-110M","bullets":["Q2 revenue $386M, +9% YoY; net income $15.7M vs net loss $43.7M prior-year quarter.","Adjusted EBITDA $54.4M ($173 PMPM) vs -$17.1M (-$49 PMPM) a year ago.","At-risk membership ~105,000, down 10% YoY on intentional network/payer rationalization.","Medical margin $97.8M ($311 PMPM); excluding payer settlements and prior-year development, $52.9M ($168 PMPM).","Raised full-year 2026 adjusted EBITDA guidance to $80-110M; revenue guidance $1.5-1.6B."],"urls":{"canonical":"https://secwatch.observer/filing/0001832511-26-000032","json":"https://secwatch.observer/filing/0001832511-26-000032.json","markdown":"https://secwatch.observer/filing/0001832511-26-000032.md","text":"https://secwatch.observer/filing/0001832511-26-000032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832511/000183251126000032/0001832511-26-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832511/000183251126000032/piii-20260810.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-10T20:04:12.058991+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}